Huiyu Pharmaceutical (688553.SH): Sodium Parecoxib and Zoledronic Acid Injection have obtained approval for overseas marketing.

Zhitong Finance APP news, Huyi Pharmaceutical (688553.SH) announced that its subsidiary Seacross (Europe) Pharma Ltd. recently received marketing approval for its products, injection of Parecoxib Sodium and Zoledronic Acid injection, from the German Federal Institute for Drugs and Medical Devices, the Dutch Health Products Regulatory Authority, and the Spanish Agency of Medicines and Medical Devices.